DHI250117P142000
- 0.45
- -1.90-80.85%
D.R. Horton Newsroom
Goldman Sachs Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $171
Goldman Sachs Maintains Buy on D.R. Horton, Lowers Price Target to $171
D.R. Horton Analyst Ratings
RBC Capital Maintains D.R. Horton(DHI.US) With Sell Rating, Cuts Target Price to $125
RBC Cuts Price Target on D.R. Horton to $125 From $145, Keeps Underperform Rating
Under the banner of the Flower, the Target Price for D.R. Horton has been lowered to 152 dollars.
UBS Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $203
DR Horton Is Maintained at Neutral by Citigroup
D.R. Horton Analyst Ratings
Citi Maintains D.R. Horton(DHI.US) With Hold Rating, Cuts Target Price to $152
DR Horton Is Maintained at Overweight by Wells Fargo
D.R. Horton Analyst Ratings
Wells Fargo Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $175
Argus Adjusts Price Target on D.R. Horton to $190 From $200
Evercore Maintains D.R. Horton(DHI.US) With Buy Rating, Raises Target Price to $212
BofA Securities Maintains D.R. Horton(DHI.US) With Buy Rating, Announces Target Price $290
Oppenheimer Maintains D.R. Horton(DHI.US) With Hold Rating
D.R. Horton Analyst Ratings
Barclays Downgrades D.R. Horton(DHI.US) to Hold Rating, Cuts Target Price to $170
KBW Downgrades D.R. Horton(DHI.US) to Hold Rating, Cuts Target Price to $183